Open Rank Clinician-Scientist, Precision Oncology

McGill University; Montreal; On-site; CAD 140,000 - 210,000; Full time

Job summary

McGill University’s Gerald Bronfman Department of Oncology, Division of Medical Oncology, invites applications for a full-time Clinician-Scientist at the ranks of Assistant, Associate, or Full Professor (Tenure Track or CAS) based at the MUHC in Montreal, Quebec.

The successful candidate will build a world-class clinical and biomedical program in precision oncology, contribute to high-volume clinical care, and lead a strong translational research effort within the Rossy Cancer Network while

Qualifications

• Hold an MD degree and licensure eligibility in Quebec.
• Subspecialty training in Medical Oncology completed.
• Royal College certification (Canada) or equivalent.
• Eligible for certification by Collège des médecins du Québec.
• Doctorate or related advanced research training is an asset.
• Strong publication record in oncology research.

Responsibilities

• Develop world-class clinical and biomedical research in precision oncology.
• Promote innovative clinical cancer care within MUHC and Cedars Cancer Centre.
• Contribute to a robust clinical trials program within the Rossy Cancer Network.
• Engage in teaching, supervision, and service on academic committees.

Skills

Bilingual English/French

Education

MD degree

Subspecialty training in Medical Oncology

Royal College certification (Canada)

Collège des médecins du Québec certification

Doctorate or equivalent asset

Strong publication record

Job description

McGill University’s Gerald Bronfman Department of Oncology, Division of Medical Oncology, invites applications for a full-time Clinician-Scientist at the ranks of Assistant, Associate, or Full Professor (Tenure Track or CAS) based at the MUHC in Montreal, Quebec.

The successful candidate will build a world-class clinical and biomedical program in precision oncology, contribute to high-volume clinical care, and lead a strong translational research effort within the Rossy Cancer Network while